CRISPR Therapeutics AG short interest in 2020
In 2020, CRISPR Therapeutics AG's disclosed short interest ran from 5.93% of shares outstanding on 15 Jan 2020 to 5.48% on 31 Dec 2020, a change of -0.45 percentage points. The year's high was 8.96% on 30 Oct 2020 and its low 4.70% on 14 Feb 2020, averaging 6.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.35 days on 30 Sep 2020. Full history: CRISPR Therapeutics AG.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 5.93% (15 Jan 2020)
- End of year
- 5.48% (31 Dec 2020)
- Change
- -0.45 pp
- High
- 8.96% (30 Oct 2020)
- Low
- 4.70% (14 Feb 2020)
- Average
- 6.18%
- Highest days to cover
- 10.35 (30 Sep 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 5.93% | 3.03 | |
| 31 Jan 2020 | 5.59% | 3.55 | |
| 14 Feb 2020 | 4.70% | 2.70 | 10-K filed, results (8-K) |
| 28 Feb 2020 | 5.17% | 2.60 | |
| 13 Mar 2020 | 5.43% | 3.65 | |
| 31 Mar 2020 | 5.37% | 3.91 | |
| 15 Apr 2020 | 5.92% | 4.40 | |
| 30 Apr 2020 | 6.58% | 5.66 | 10-Q filed, results (8-K) |
| 15 May 2020 | 7.00% | 4.57 | |
| 29 May 2020 | 6.37% | 3.94 | |
| 15 Jun 2020 | 6.29% | 5.24 | |
| 30 Jun 2020 | 6.78% | 4.09 | |
| 15 Jul 2020 | 4.86% | 1.88 | |
| 31 Jul 2020 | 6.16% | 5.98 | 10-Q filed, results (8-K) |
| 14 Aug 2020 | 6.46% | 6.30 | |
| 31 Aug 2020 | 6.35% | 4.70 | |
| 15 Sep 2020 | 6.68% | 6.31 | |
| 30 Sep 2020 | 6.85% | 10.35 | |
| 15 Oct 2020 | 7.55% | 4.50 | |
| 30 Oct 2020 | 8.96% | 4.75 | 10-Q filed, results (8-K) |
| 13 Nov 2020 | 6.64% | 6.03 | |
| 30 Nov 2020 | 6.09% | 7.20 | |
| 15 Dec 2020 | 5.10% | 1.99 | |
| 31 Dec 2020 | 5.48% | 1.73 |
See also: CRISPR Therapeutics AG's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.